Balyasny Asset Management LLC Abbott Laboratories Put Options Transaction History

Balyasny Asset Management LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.48 Million - $3.88 Million	34,500 Added 60.74%	91,300 $9.49 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $1.26 Million - $1.39 Million	11,500 Added 25.39%	56,800 $6.46 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $974,052 - $1.19 Million	10,800 Added 31.3%	45,300 $4.99 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $277,037 - $332,398	2,900 Added 9.18%	34,500 $3.34 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $2.02 Million - $2.25 Million	20,000 Added 172.41%	31,600 $3.45 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.1 Million - $1.29 Million	11,600 New	11,600 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $886,616 - $980,856	-7,600 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $2.37 Million - $2.79 Million	-22,400 Reduced 74.67%	7,600 $881,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $2.75 Million - $3.34 Million	30,000 New	30,000 $3.27 Million

3,161

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.